Id1 and Id3 co-expression correlates with clinical outcome in stage III-N2 non-small cell lung cancer patients treated with definitive chemoradiotherapy

Subclassification of Non-Small Cell Lung Cancer by Cytologic Sampling: A Logical Approach with Selective Use of Immunocytochemistry

(2012) Hillary Z. Kimbrell et al.   ACTA CYTOLOGICA

ID1 and ID3 Regulate the Self-Renewal Capacity of Human Colon Cancer-Initiating Cells through p21

(2012) Catherine A. O'Brien et al.   CANCER CELL

The multimodal management of locally advanced N2 non-small cell lung cancer: is there a role for surgical resection? A single institution’s experience

(2012) Joaquim Bosch-Barrera et al.   Clinical & Translational Oncology

Inhibitor of Differentiation-1 as a Novel Prognostic Factor in NSCLC Patients with Adenocarcinoma Histology and Its Potential Contribution to Therapy Resistance

(2011) M. Ponz-Sarvise et al.   CLINICAL CANCER RESEARCH

Targeting Id1 and Id3 by a specific peptide aptamer induces E-box promoter activity, cell cycle arrest, and apoptosis in breast cancer cells

(2010) Demissew S. Mern et al.   BREAST CANCER RESEARCH AND TREATMENT

Long-Term Follow-Up of a Phase I/II Trial of Dose Escalating Three-Dimensional Conformal Thoracic Radiation Therapy with Induction and Concurrent Carboplatin and Paclitaxel in Unresectable Stage IIIA/B Non-small Cell Lung Cancer

(2010) Thomas E. Stinchcombe et al.   Journal of Thoracic Oncology

Treatment Outcomes of Different Prognostic Groups of Patients on Cancer and Leukemia Group B Trial 39801: Induction Chemotherapy Followed by Chemoradiotherapy Compared with Chemoradiotherapy Alone for Unresectable Stage III Non-small Cell Lung Cancer

(2010) Thomas E. Stinchcombe et al.   Journal of Thoracic Oncology

The stem cell gene “inhibitor of differentiation 1” (ID1) is frequently expressed in non-small cell lung cancer

(2010) Sacha I. Rothschild et al.   LUNG CANCER

The novel Akt inhibitor Palomid 529 (P529) enhances the effect of radiotherapy in prostate cancer

(2009) R Diaz et al.   BRITISH JOURNAL OF CANCER

Activation of a prometastatic gene expression program in hypoxic neuroblastoma cells

(2009) Preamrudee Poomthavorn et al.   ENDOCRINE-RELATED CANCER

Molecular predictive and prognostic markers in non-small-cell lung cancer

(2009) Linda E Coate et al.   LANCET ONCOLOGY

Increased Expression of Id Family Proteins in Small Cell Lung Cancer and its Prognostic Significance

(2008) L. Kamalian et al.   CLINICAL CANCER RESEARCH

Id1/Id3 Knockdown Inhibits Metastatic Potential of Pancreatic Cancer

(2008) Yasutaka Shuno et al.   JOURNAL OF SURGICAL RESEARCH